Research · Source update
ClinicalTrials.gov results are not the same as approval
Source context: Read the linked original research or registry entry for study status and limitations.
In September, results from Eli Lilly's ATTAIN-2 orforglipron trial appeared in the federal ClinicalTrials.gov registry. That event deserves coverage, but the wording matters: posting study findings is not the same as FDA approval. Here we walk through the difference between a trial result, a publication and permission to market a drug.
Regulatory terminology
In September, results from Eli Lilly's ATTAIN-2 orforglipron trial appeared in the federal ClinicalTrials.gov registry. That event deserves coverage, but the wording matters: posting study findings is not the same as FDA approval. Here we walk through the difference between a trial result, a publication and permission to market a drug.
What does the original source show?
A registry record can include submitted outcomes before or apart from regulatory decisions. A posting date is not a marketing authorization date, and trial results should not be conflated with a drug label.
Why does it matter?
Think of drug development as several checkpoints. Researchers first register a planned study, then conduct it, then report findings. Regulators review submitted evidence separately before deciding whether a drug can be marketed for a particular condition. One checkpoint is not proof that the next has happened.
What should readers keep in mind?
This distinction matters when you read words such as 'new', 'approved' and 'breakthrough'. A newly posted results table may be genuinely useful news for researchers without changing which medicines someone can get by prescription today. When planning care, always verify current FDA-approved product information.
The practical takeaway
Check the FDA label separately for current indications and availability.
The bottom line
Check the FDA label separately for current indications and availability.
Written and published by MyDosePro as an educational explanation of publicly available evidence. The linked primary source is dated 2026-09-04. We identify trial registrations separately from published results and do not provide individual prescribing advice.
Primary sourceSource event or update: 2026-09-04. Our interpretation is educational and does not replace medical or insurance advice.